Depression
Not yet recruitingStudy of Psilocybin for Patients with Treatment-Resistant Depression
- Disease:Depression
- Substances:Psilocybine
Austria- Participants:18–64 years · 65+ years
- Substances:Psilocybine
- Sponsor:LKH Graz II
Rare diseases
Investigational molecules
Locations
Wagner Jauregg Platz 1, 8053 Graz, Austria
The clinical research activity is centered on treatment-resistant depression, with interest in interventions for patients whose depressive symptoms have not responded adequately to standard care.
The sponsor’s trial portfolio in this area reflects a focus on advancing clinical options for major depressive disorder when conventional therapies are insufficient.
LKH Graz II runs clinical trials in conditions such as Depression, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.